Trial · NCT07902414
Mi2000 TICI Follow-up
NCT07902414, Recruiting, MED-EL Elektromedizinische Geräte GmbH
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Mi2000 TICI Follow-up. Trials, record NCT07902414. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07902414
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Mi2000 TICI Follow-up
- NCT number
- NCT07902414
- Status
- Recruiting
- Enrollment
- 36 participants, estimated
- Lead sponsor
- MED-EL Elektromedizinische Geräte GmbH
- Conditions
- Hearing Loss, Binaural, Cochlear Implantation
- Interventions
- Cochlear Implantation
- First posted
- 2026-10-28
- Last updated
- 2026-11-12
Source ClinicalTrials.gov
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Word Test in Quiet | Pre-op to 36 months after first fitting | Word recognition in quiet, on a scale from 0 to 100% correct, higher scores indicate better outcomes |
| Secondary | Nijmegen Cochlear Implant Questionnaire (NCIQ) | Pre-op to 36 months after first fitting | Disease specific Quality of Life, overall score is on a scale from 0 to 100, higher numbers indicating better outcomes |
| Secondary | Speech, Spatial, Quality of Hearing (SSQ12) | Pre-op to 36 months after first fitting | Speech, Spatial and Quality of hearing scale from 0 to 10, higher numbers indicating better outcomes |
| Other | Word test in quiet | through study completion, an average of 60 months after first fitting | Word recognition in quiet, on a scale from 0 to 100% correct, higher scores indicate better outcomes |
| Other | Sentence Test in Noise | through study completion, an average of 60 months after first fitting | Oldenburg Matrix Test, results measured in dB signal-to-noise ratio (SNR) with a range of +30 to -10 dB SNR, lower values indicating better outcomes |
| Other | Health Utility Index Mark 3 (HUI3) | through study completion, an average of 60 months after first fitting | Health utility scale: 1.00: Perfect health. 0.00: Death. Negative values: States worse than death. |
| Other | Nijmegen Cochlear Implant Questionnaire (NCIQ) | through study completion, an average of 60 months after first fitting | Disease specific Quality of Life, overall score is on a scale from 0 to 100, higher numbers indicating better outcomes |
| Other | Speech, Spatial, Quality of Hearing (SSQ12) | through study completion, an average of 60 months after first fitting | Speech, Spatial and Quality of hearing scale from 0 to 10, higher numbers indicating better outcomes |
| Other | Hearing Implant Sound Quality Index (HISQUI) | through study completion, an average of 60 months after first fitting | Sound quality score ranging from 19 (very poor sound quality) to 133 (very good sound quality) |
| Other | Tinnitus functional index (TFI) | through study completion, an average of 60 months after first fitting | Tinnitus questionnaire measures the severity and negative impact of tinnitus on a 0 (Not a Problem / Slight Tinnitus) to 100 (Very Big Problem / Very Severe Tinnitus) scale |
1 to 10 of 11Source ClinicalTrials.gov
See all 11 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07902414
GET https://conductscience.org/api/trials/v1/NCT07902414/registered